Deliberating Over Danger

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

Written byThe Scientist
| 19 min read

Register for free to listen to this article
Listen with Speechify
0:00
19:00
Share

SEAN MCCABE

In September 2011, Ron Fouchier of Erasmus Medical Center in Rotterdam, the Netherlands, presented some shocking results at the annual conference of the European Scientific Working Group on Influenza: he and his colleagues had created a mutant version of the H5N1 avian flu virus that could be transmitted through the air between ferrets. Not long after, news began to circulate of a similar creation in the lab of Yoshihiro Kawaoka of the University of Wisconsin, Madison. Fouchier and Kawaoka submitted their studies for publication to Science and Nature, respectively, sparking a heated debate over the potential consequences of publishing such research, whether the risky viruses should have been created at all, and, of course, how comparable work should be regulated going forward. In the following ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies